NCT04509011View on ClinicalTrials.gov

Autofluorescence vs Clinical Assessment of Parathyroid Glands During Thyroid Surgery

NACompletedINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

July 31, 2023

Conditions
Hypoparathyroidism Postprocedural
Interventions
DEVICE

Fluobeam® LX

Fluobeam®-LX is used to identify and evaluate parathyroid glands using auto-fluorescence during thyroid surgery.

Trial Locations (5)

1030

Rudolfstiftung, Vienna

5021

Haukeland University Hospital, Bergen

22185

Skåne University Hospital, Department of Surgery, Lund, Lund

41345

Sahlgrenska University Hospital, Gothenburg

31-008

Jagiellonian University Medical College, Krakow

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

Jagiellonian University

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Hospital Rudolfstiftung

OTHER

lead

Region Skane

OTHER

NCT04509011 - Autofluorescence vs Clinical Assessment of Parathyroid Glands During Thyroid Surgery | Biotech Hunter | Biotech Hunter